January 13, 2024
Healthcare cost and utilization for chimeric antigen receptor (CAR) T-cell therapy in the treatment of pediatric acute lymphoblastic leukemia: A commercial insurance claims database analysis
Hoover A, Reimche P, Watson D, Tanner L, Gilchrist L, Finch M, Messinger YH, Turcotte LM. Cancer Rep (Hoboken). 2024 Feb;7(2):e1980.